These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1342286)

  • 1. Thrombosis and cardiovascular disease.
    Meade TW
    Ann Epidemiol; 1992 Jul; 2(4):353-64. PubMed ID: 1342286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemostatic function and arterial disease.
    Meade TW
    Br Med Bull; 1994 Oct; 50(4):755-75. PubMed ID: 7804729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet counts and aggregation measures in the incidence of ischaemic heart disease (IHD).
    Meade TW; Cooper JA; Miller GJ
    Thromb Haemost; 1997 Aug; 78(2):926-9. PubMed ID: 9268196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemostasis disturbances in myocardial ischemia].
    Habis M; Gonzalez C; Jacq L; Pezzano M; Schaison F; Lardoux H
    Ann Cardiol Angeiol (Paris); 2000 Dec; 49(8):480-7. PubMed ID: 12555436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dynamics of morphological structures of platelets in patients with ischemic heart disease in dependence on blood levels of fatty acids].
    Sokolov EI; Buriachkovskaia LI; Zykova AA; Goloborodova IV
    Kardiologiia; 2011; 51(1):29-33. PubMed ID: 21626799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraceptives, clotting factors, and thrombosis.
    Meade TW
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):758-61. PubMed ID: 6801980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombogenic factors and recurrent coronary events.
    Moss AJ; Goldstein RE; Marder VJ; Sparks CE; Oakes D; Greenberg H; Weiss HJ; Zareba W; Brown MW; Liang CS; Lichstein E; Little WC; Gillespie JA; Van Voorhees L; Krone RJ; Bodenheimer MM; Hochman J; Dwyer EM; Arora R; Marcus FI; Watelet LF; Case RB
    Circulation; 1999 May; 99(19):2517-22. PubMed ID: 10330382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework.
    Lancet; 1998 Jan; 351(9098):233-41. PubMed ID: 9457092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship of platelet reactivity to the occurrence of post-stenting ischemic events: emergence of a new cardiovascular risk factor.
    Gurbel PA
    Rev Cardiovasc Med; 2006; 7 Suppl 4():S20-8. PubMed ID: 17224887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of oral flora on platelets: possible consequences in cardiovascular disease.
    Herzberg MC; Meyer MW
    J Periodontol; 1996 Oct; 67(10 Suppl):1138-42. PubMed ID: 8910832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial.
    Topol EJ; Easton JD; Amarenco P; Califf R; Harrington R; Graffagnino C; Davis S; Diener HC; Ferguson J; Fitzgerald D; Shuaib A; Koudstaal PJ; Theroux P; Van de Werf F; Willerson JT; Chan R; Samuels R; Ilson B; Granett J
    Am Heart J; 2000 Jun; 139(6):927-33. PubMed ID: 10827369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic effects of combining activated protein C and urokinase in nonhuman primates.
    Gruber A; Harker LA; Hanson SR; Kelly AB; Griffin JH
    Circulation; 1991 Dec; 84(6):2454-62. PubMed ID: 1835678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation and regulation of platelet and fibrin hemostatic plug.
    Hawiger J
    Hum Pathol; 1987 Feb; 18(2):111-22. PubMed ID: 3804319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The pathophysiological basis of the destabilization of the clinical course in ischemic heart disease].
    Babov KD; Shumakov VO; Bratus' VV
    Fiziol Zh (1994); 1996; 42(1-2):17-24. PubMed ID: 8991709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma fibrinogen and factor VII as risk factors for cardiovascular disease.
    Kelleher CC
    Eur J Epidemiol; 1992 May; 8 Suppl 1():79-82. PubMed ID: 1505657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemostatic variables and ischemic cardiovascular disease: do we need a concerted effort for more profitable future clinical investigations?
    Di Minno G; Mancini FP; Margaglione M
    Cardiovasc Drugs Ther; 1997 Jan; 10(6):743-9. PubMed ID: 9110118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinolytic and thrombotic factors in atherosclerosis and IHD: the influence of triglyceride rich lipoproteins (TGRLP).
    Bradley WA; Booyse FM; Gianturco SH
    Atherosclerosis; 1994 Aug; 108 Suppl():S31-9. PubMed ID: 7802727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypercoagulability and ischaemic heart disease.
    Meade TW
    Blood Rev; 1987 Mar; 1(1):2-8. PubMed ID: 3332083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond.
    Xu XR; Zhang D; Oswald BE; Carrim N; Wang X; Hou Y; Zhang Q; Lavalle C; McKeown T; Marshall AH; Ni H
    Crit Rev Clin Lab Sci; 2016 Dec; 53(6):409-30. PubMed ID: 27282765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of vegetarian diet, plant foods, and phytochemicals on hemostasis and thrombosis.
    Rajaram S
    Am J Clin Nutr; 2003 Sep; 78(3 Suppl):552S-558S. PubMed ID: 12936949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.